Literature DB >> 19085229

Australian men's experiences during a microbicide male tolerance study.

Susan L Rosenthal1, Wendy Holmes, Lisa Maher.   

Abstract

Microbicides currently in development have the potential to provide new options for the prevention of sexually transmitted infections if proven safe and efficacious. We examined the experiences of healthy male volunteers in a male tolerance study in Victoria, Australia in relation to trial participation and product use. Men (N=36) enrolled in a seven-day, phase 1 clinical safety trial of SPL7013 were interviewed pre and post-use of the gel using a semi-structured interview guide. Interviews were digitally recorded and transcribed verbatim, and transcripts were analysed using a framework approach. All but one man completed the trial. The median age was 34 years (range 22-67 years). Most men had little pre-study knowledge of microbicides and almost all participated for altruistic or personal reasons. Men expressed few concerns about product safety during the trial and indicated trust in the information received through the consent process and from study staff. Three men were non-adherent to the request to be abstinent and an additional two did not refrain from masturbation. Most were positive about the gel, although they described it as "sticky" and found that it stuck to clothes, bed sheets and pubic hair. The type of applicator used was unfamiliar to the men, and some found it "clinical" in appearance. Men are willing to participate in male tolerance studies, often for altruistic reasons. However, counseling about ways to maintain abstinence and further research to inform anticipatory guidance regarding the "sticky" quality of gels, may be important.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19085229      PMCID: PMC2605281          DOI: 10.1080/09540120802084958

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  18 in total

1.  Assessing microbicide acceptability: a comprehensive and integrated approach.

Authors:  Kathleen M Morrow; Monica S Ruiz
Journal:  AIDS Behav       Date:  2007-06-26

2.  Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda.

Authors:  G Green; R Pool; S Harrison; G J Hart; J Wilkinson; S Nyanzi; J A Whitworth
Journal:  Soc Sci Med       Date:  2001-02       Impact factor: 4.634

3.  Recommendations for the clinical development of topical microbicides: an update.

Authors:  C Mauck; Z Rosenberg; L Van Damme
Journal:  AIDS       Date:  2001-05-04       Impact factor: 4.177

4.  Men's attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA.

Authors:  C Coggins; K Blanchard; B Friedland
Journal:  Reprod Health Matters       Date:  2000-05

5.  Factors affecting African-American participation in AIDS research.

Authors:  S Sengupta; R P Strauss; R DeVellis; S C Quinn; B DeVellis; W B Ware
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

6.  Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.

Authors:  M E Bentley; K M Morrow; A Fullem; M A Chesney; S D Horton; Z Rosenberg; K H Mayer
Journal:  Fam Plann Perspect       Date:  2000 Jul-Aug

7.  Women's willingness to participate in microbicide trials in Northern Thailand.

Authors:  K Tharawan; C Manopaiboon; C Ellertson; K Limpakarnjanarat; S Chaikummao; P H Kilmarx; K Blanchard; C Coggins; T D Mastro; C Elias
Journal:  J Acquir Immune Defic Syndr       Date:  2001-10-01       Impact factor: 3.731

8.  Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel: 3 randomized trials in healthy low-risk men and HIV-positive men.

Authors:  Stephen R Tabet; Marianne M Callahan; Christine K Mauck; Fang Gai; Anne S Coletti; Albert T Profy; Thomas R Moench; Lydia E Soto-Torres; Alfred N Poindexter III; Ron G Frezieres; Terri L Walsh; Clifton W Kelly; Barbra A Richardson; Lut Van Damme; Constance L Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-01       Impact factor: 3.731

9.  A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis.

Authors:  Marcus Y Chen; Iona Y Millwood; Handan Wand; Mary Poynten; Matthew Law; John M Kaldor; Steve Wesselingh; Clare F Price; Laura J Clark; Jeremy R A Paull; Christopher K Fairley
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-01       Impact factor: 3.731

10.  Dextrin sulfate as a vaginal microbicide: randomized, double-blind, placebo-controlled trial including healthy female volunteers and their male partners.

Authors:  Naomi Low-Beer; Rhian Gabe; Sheena McCormack; Valerie S Kitchen; Charles J Lacey; Andrew J Nunn
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-01       Impact factor: 3.731

View more
  2 in total

1.  Perceptions of reimbursement for clinical trial participation.

Authors:  Carmen Radecki Breitkopf; Melissa Loza; Kathleen Vincent; Thomas Moench; Lawrence R Stanberry; Susan L Rosenthal
Journal:  J Empir Res Hum Res Ethics       Date:  2011-09       Impact factor: 1.742

2.  Acceptability of optical coherence tomography and abstinence requirements among women participating in microbicide safety trials.

Authors:  Carmen Radecki Breitkopf; Melissa Loza; Kathleen Vincent; Thomas Moench; Lawrence R Stanberry; Susan L Rosenthal
Journal:  Sex Transm Dis       Date:  2012-01       Impact factor: 2.830

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.